SCHEMBL6901782

SCHEMBL6901782

CN(O)C(=O)CN1CCN2CCN(CC1)CCN(CC(=O)N(C)O)CC2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
DRD4 P21917 1/20 0.36
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
SIGMAR1 Q99720 3/20 0.34
KDM4E B2RXH2 3/20 0.33
MDM2 Q00987 1/20 0.33
TSHR P16473 1/20 0.32
PKM P14618 1/20 0.32
CACNA2D1 P54289 1/20 0.32
CACNA1B Q00975 1/20 0.32
CACNB1 Q02641 1/20 0.32
CACNA1C Q13936 1/20 0.32
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975706 0.93 ALDH1A1 (0.48) ALDH1A1DRD4MEN1POLBKMT2A
SCHEMBL31679340 0.85 HSD17B10 (0.45) ALDH1A1DRD4MEN1POLBKMT2A
SCHEMBL31679390 0.85 HSD17B10 (0.45) ALDH1A1DRD4MEN1POLBKMT2A
SCHEMBL1377151 0.81 ALDH1A1 (0.40) ALDH1A1DRD4MEN1POLBKMT2A
SCHEMBL14036400 0.80 SIGMAR1 (0.44) ALDH1A1MEN1POLBKMT2ASIGMAR1
SCHEMBL1376227 0.79 ALDH1A1 (0.39) ALDH1A1DRD4MEN1POLBKMT2A
SCHEMBL8393969 0.78 SIGMAR1 (0.53) ALDH1A1MEN1KMT2ASIGMAR1
SCHEMBL13180462 0.76 ALDH1A1 (0.38) ALDH1A1MEN1KMT2ASIGMAR1KDM4E
SCHEMBL15043685 0.71 ALDH1A1 (0.59) ALDH1A1DRD4MEN1KMT2ASIGMAR1
SCHEMBL24120730 0.71 DRD4 (0.41) ALDH1A1DRD4MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1382332-A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent Chelator LLC (US) 2004-01-21 EP disclosed
US-6469162-B1 SUCH COMPOUNDS INHIBIT MAMMALIAN, BACTERIAL, AND FUNGAL CELL REPLICATION AND ARE USEFUL IN THE TREATMENT OF NEOPLASIA, INFECTION, INFLAMMATION, IMMUNE REPONSE, AND IN TERMINATION OF PREGNANCY CONCAT, LTD. 2002-10-22 US disclosed
US-6165996-A Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis CONCAT, INC. (US) 2000-12-26 US disclosed
EP-0955044-A2 Method of inhibiting bacterial or fungal growth using a complexing agent CONCAT LTD. (US) 1999-11-10 EP disclosed
EP-0841951-A2 COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS, AND THEIR USE IN MEDICAL THERAPY AND DIAGNOSIS CONCAT LTD. (US) 1998-05-20 EP disclosed
WO-1997001360-A9 COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS AND THEIR USE IN MEDICAL THERAPY AND DIAGNOSIS 1997-07-17 WO disclosed
WO-1997001360-A2 COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS AND THEIR USE IN MEDICAL THERAPY AND DIAGNOSIS CONCAT, LTD. (US) 1997-01-16 WO disclosed